Literature DB >> 2067645

Intrathecal baclofen for intractable axial dystonia.

R K Narayan1, P G Loubser, J Jankovic, W H Donovan, C F Bontke.   

Abstract

Following spinal instrumentation for scoliosis, a patient developed intractable axial dystonia refractory to conservative medical management. We describe the successful treatment of this dystonia with a continuous infusion of intrathecal baclofen and the subsequent long-term management.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2067645     DOI: 10.1212/wnl.41.7.1141

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Abnormal activation of the motor cortical network in idiopathic scoliosis demonstrated by functional MRI.

Authors:  Julio Domenech; G García-Martí; L Martí-Bonmatí; C Barrios; J M Tormos; A Pascual-Leone
Journal:  Eur Spine J       Date:  2011-04-16       Impact factor: 3.134

Review 2.  Intrathecal baclofen for childhood hypertonia.

Authors:  A Leland Albright
Journal:  Childs Nerv Syst       Date:  2007-06-29       Impact factor: 1.475

Review 3.  Treatment of dystonia.

Authors:  Mary Ann Thenganatt; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 4.  Surgical management of spasticity.

Authors:  Andrew Roberts
Journal:  J Child Orthop       Date:  2013-10-06       Impact factor: 1.548

Review 5.  Intraventricular vs intrathecal baclofen for secondary dystonia: a comparison of complications.

Authors:  Brandon G Rocque; A Leland Albright
Journal:  Neurosurgery       Date:  2012-06       Impact factor: 4.654

Review 6.  Treatment strategies for dystonia.

Authors:  Leslie J Cloud; H A Jinnah
Journal:  Expert Opin Pharmacother       Date:  2010-01       Impact factor: 3.889

Review 7.  A benefit-risk assessment of baclofen in severe spinal spasticity.

Authors:  Alessandro Dario; Giustino Tomei
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

8.  Intrathecal baclofen therapy after liver transplant in a patient with Crigler-Najjar syndrome.

Authors:  Napala R Pratini; Jacob A Neufeld
Journal:  PM R       Date:  2013-12-21       Impact factor: 2.298

9.  Treatment of classic pantothenate kinase-associated neurodegeneration with deferiprone and intrathecal baclofen.

Authors:  Napala R Pratini; Nancy Sweeters; Elliott Vichinsky; Jacob A Neufeld
Journal:  Am J Phys Med Rehabil       Date:  2013-08       Impact factor: 2.159

Review 10.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.